Product Safety Recalls

Product Recall Tracker

ESTRADIOL Recall D-0543-2024

Description: Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1191-8

ESTRADIOL Recall D-0543-2024 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0543-2024
Event ID94649
BrandESTRADIOL
Generic NameESTRADIOL
ManufacturerESTRADIOL
Original Package?1
Active SubstanceESTRADIOL
Drug RouteTRANSDERMAL
DistributionNationwide within the United States
Quantity13,440 units
Recall ReasonFailed Impurities/Degradation Specifications.
Drug ClassificationClass III
Drug Code Info20240612
Product NDC70710-1191 70710-1192 70710-1193
Product NUIM0447348 N0000175825 N0000000100
Drug UPC0370710119188 0370710119485 0370710119287
Pharma Class (EPC)Estrogen [EPC]
Pharma Class (CS)Estradiol Congeners [CS]
Recall Initiation Date20240516
Report Date20240612
Classification Date20240606
Address73 Route 31 NN/A
Pennington, NJ 08534-3601
United States
Recalling FirmZydus Pharmaceuticals (USA) Inc
Initial Notification Letter
Unique Ingredient Identifier4TI98Z838E
Drug Application NumberANDA206241
Structured Product Labeling (SPL ID)51a2adf6-a381-42cb-bf3e-8c83a7cfe738
Structured Product Labeling (SPL Set ID)839fe7ae-6835-4d6a-b6b1-ca7f062caa4f
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.